Imatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1 - - GEO DataSets - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Full record GDS4177

Imatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1

Analysis of CML cell lines (KU-812, KCL-22, and JURL-MK1) treated with tyrosine kinase inhibitor imatinib. Imatinib inhibits oncogenic BCR-ABL1, a tyrosine kinase present in most CML patients. Results provide insight into molecular mechanisms underlying imatinib inhibition of CML.

Organism:: Homo sapiens

Type:: Expression profiling by array, count, 2 agent, 3 cell line sets

Platform:: GPL570
Series:: GSE24493
6 Samples

Download data: CEL

DataSet

Accession:: GDS4177

ID:: 4177

PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet

Supplemental Content

Related information

PubMed
Related PubMed entries
Full text in PMC
PMC links
Similar studies
Similar studies
GEO Profiles
Related GEO
BioProject
BioProject links
GEO DataSets
Related GEO DataSets
Taxonomy
Taxonomy

Important Links

Recent activity

Clear Turn Off Turn On

Related DataSets for GEO Profiles (Select 82947021) (1)
GEO DataSets
Imatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JU...
Imatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
Accession: GDS4177

GEO DataSets
Full text in PMC (nucleotide) for Gene (Select 483) (114)
PMC
Homo sapiens transmembrane protein 134 (TMEM134), transcript variant 8, non-codi...
Homo sapiens transmembrane protein 134 (TMEM134), transcript variant 8, non-coding RNA
gi|1701970981|ref|NR_073413.2|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Genes & Expression > Gene Expression Omnibus (GEO) Datasets